PER
Click for more information
5.88% 8.0¢ percheron therapeutics limited

Ann: Long COVID-19 strategic collaboration with US Experts, page-6

  1. mephistophles
    1,066 Posts.
    lightbulb Created with Sketch. 498
    clock Created with Sketch.
    24/02/22
    13:56
    Post #: 59792133
    I believe that most (~80% iirc) infected patients with SARS-CoV-2 also end up with "long COVID" symptoms. Kind of interesting - I swear we were asking about ATL1102 wrt SARS-CoV-2... err, yep. Over a year ago:

    https://hotcopper.com.au/posts/50666779/
    ANP Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.005(5.88%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $47.42K 590.5K

Buyers (Bids)

No. Vol. Price($)
2 34238 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 94978 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.